C12N 2830/006
Tet repressible
Official title: tet repressible
C12N2830/006 (Tet repressible) appears on 142 US grants and 187 published applications in this corpus.
Search patents in C12N- Granted patents
- 142
- Published applications
- 187
- Assignees
- 110
- Inventors
- 351
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 7 | 0 |
| 1999 | 9 | 0 |
| 2000 | 6 | 0 |
| 2001 | 7 | 3 |
| 2002 | 7 | 8 |
| 2003 | 4 | 18 |
| 2004 | 1 | 11 |
| 2005 | 3 | 5 |
| 2006 | 2 | 7 |
| 2007 | 4 | 6 |
| 2008 | 4 | 8 |
| 2009 | 2 | 8 |
| 2010 | 8 | 10 |
| 2011 | 8 | 3 |
| 2012 | 1 | 9 |
| 2013 | 3 | 8 |
| 2014 | 4 | 5 |
| 2015 | 9 | 4 |
| 2016 | 9 | 5 |
| 2017 | 4 | 12 |
| 2018 | 8 | 7 |
| 2019 | 3 | 3 |
| 2020 | 3 | 10 |
| 2021 | 4 | 5 |
| 2022 | 1 | 8 |
| 2023 | 9 | 4 |
| 2024 | 5 | 9 |
| 2025 | 2 | 8 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Adeno-associated virus (AAV) producer cell line and related methods20 Jan 2026US 12,529,074 B2Lonza Walkersville, Inc.
- Generation regulatable fusogenic oncolytic herpes simplex virus type 1 virus and methods of use30 Dec 2025US 12,509,662 B2The Brigham and Women's Hospital, Inc.
- Expression vector and method20 May 2025US 12,305,185 B2Mount Spec Investments Pty Ltd
- Automated production of viral vectors31 Dec 2024US 12,180,511 B2Lonza Walkersville, Inc.
- Bacillus subtilis efficiently-induced expression system based on artificial series promoter24 Sep 2024US 12,098,373 B2Jiangnan University
- A method for detecting protein targets of an enzyme using a biotin ligase20 Aug 2026US 2026/0243776 A1Leibniz-Institut Fur Alternsforschung—Fritz-Lipmann-Institut E.V. (Fli)
- Tet-r expression cassettes and cell lines16 Jul 2026US 2026/0201417 A1Cevec Pharmaceuticals GmbH
- Systems for production of transducing particles, methods, kits, compositions and uses thereof26 Mar 2026US 2026/0083787 A1Ramot at Tel-Aviv University Ltd.
- Methods of producing an enveloped virus27 Nov 2025US 2025/0361491 A1CSL Behring GmbH
- Method of delivery of fusogenic oncolytic virus and therapeutic molecules6 Nov 2025US 2025/0339481 A1The Brigham and Women S Hospital, Inc.
Most cited
By later US patents
- Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters186US 5,464,758 A1995
- Methods for regulating gene expression170US 5,814,618 ABASF SE · 1998
- Compositions and methods for helper-free production of recombinant adeno-associated viruses159US 6,953,690 B1The Trustees of the University of Pennsylvania · 2005
- Tetracycline regulated transcriptional modulators with altered DNA binding specificities102US 5,589,362 ABASF SE · 1996
- Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters99US 5,650,298 ABASF SE · 1997